Sanofi (SNY) Q4 2023 Earnings Call Transcript : vimarsana.co

SNY earnings call for the period ending December 31, 2023.

Related Keywords

United Kingdom , Ireland , Paris , France General , France , China , Norway , Japan , United States , Spain , Dubai , Dubayy , United Arab Emirates , Luisa Hector Berenberg , Societe Generale , Francois Xavier Roger , Thomas Triomphe , Richard Vosser Jpmorgan , Tim Anderson , Phouman Ashrafian , Enregistrement Universel , Luisa Hector , Simon Baker Redburn , Paul Hudson , Graham Parry , David Risinger Leerink , Gary Steventon , Peter Welford , Richard Vosser , Julie Van Ongevalle , Olivier Charmeil , Simon Baker , David Risinger , Brian Foard , America Merrill Lynch , Peter Welford Jefferies , Rajesh Kumar , Eva Schaefer Jansen , Genmed Aubagio , Florent Cespedes , Jo Walton , Company Analyst , Astrazeneca , Foundation Patient , Dillard , Houman Ashrafian Global Head Of Research , Graham Parry Bank , Tim Anderson Wolfe Research Analyst , Nestle , Motley Fool Stock Advisor , Stock Advisor , Xavier Roger , General Medicines , Consumer Healthcare , Science Based Targets , Patient Care Pathways , Business Unit Head , Specialty Care , Track Designation , Vaccines Day , Fast Track Designation , General Medicine , Capital Markets , South Hemisphere , North America , Western Europe , Wolfe Research , Redburn Partners , Sanofi , Chief Executive Officer , Jean Baptiste De Chatillon , Global Head , Global Business Unit ,